betamethasone-17,21-dipropionate has been researched along with Facial Dermatoses in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nixon, R; Shen, S; Wong, GN | 1 |
| Darley, CR; Hawk, JL; Sahni, D | 1 |
| Hessel, A; Zyniewicz, K | 1 |
3 other study(ies) available for betamethasone-17,21-dipropionate and Facial Dermatoses
| Article | Year |
|---|---|
Severe allergic contact dermatitis caused by topical bufexamac requiring hospitalization.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Bufexamac; Chemotherapy, Adjuvant; Dermatitis, Allergic Contact; Edema; Erythema; Facial Dermatoses; Histamine Antagonists; Hospitalization; Humans; Methylprednisolone; Ointments | 2019 |
Glaucoma induced by periorbital topical steroid use--a rare complication.
Topics: Administration, Cutaneous; Adult; Betamethasone; Drug Administration Schedule; Eczema; Eyelid Diseases; Facial Dermatoses; Female; Glaucoma; Glucocorticoids; Humans; Vision Disorders | 2004 |
Facial blanching caused by superpotent corticosteroids.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Seborrheic; Facial Dermatoses; Glucocorticoids; Humans; Male; Pigmentation Disorders | 1991 |